MedTrace Logo

Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility

NCT00100269 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-05-03

No results posted yet for this study

Summary

Oxidative stress related damage to sperm is believed to be a major cause of male infertility. The object of the Menevit study is to investigate the role of a novel anti-oxidant preparation (Menevit) on sperm function, embryo quality and pregnancy rates in an in vitro fertilization (IVF) setting.

Conditions

  • Infertility, Male
  • Oxidative Stress

Interventions

DRUG

Menevit anti-oxidant

Sponsors & Collaborators

  • Repromed

    lead OTHER

Principal Investigators

  • Kelton P Tremellen, MB BS (Hons) PhD · Repromed, University of Adelaide

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2006-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00100269 on ClinicalTrials.gov